Clinical Trial: Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Solid Tumors
Study Type: INTERVENTIONAL
Official Title: Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)
Brief Summary:
To find the recommended dose of TROP2- CAR-NK cells that can be given to patients with advanced forms of solid tumors.
Read more